V
Vitroscope
Norway · Biotech
Vitroscope builds laboratory platforms that keep living tissue under controlled fluid flow for drug discovery and disease research.
Product
Its vitro.alive benchtop system combines perfusion with control of oxygen, pH and temperature, allowing researchers to observe tissue responses over several days. It works with standard inverted microscopes and existing tissue models.
Development
The Trondheim company is also developing vitro.scale for higher-throughput experiments. Customer testing is planned for 2027, before a proposed 2028 launch.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5M | Cerberus Ventures — LeadYZR Capital — LeadArcas Ventures — ParticipantCarles Reina — ParticipantDevico Invest — ParticipantFàtima Godall — ParticipantGolden Egg Check — ParticipantOskari Pétas — Participant |